Mettler-Toledo Product Inspection is launching new personalised virtual factory tours that will help pharma and biopharma manufacturers to improve quality assurance, regulatory compliance and consumer safety standards. 

The product inspection technologies on display during the virtual tours are designed to detect contaminants and help ensure high standards of quality in pharma products including track and trace and serialisation. They, therefore, help to protect consumers and patients and enable pharma and biopharma manufacturers to reduce the risks of experiencing product recalls, factory closures, fines from regulators and loss of business and brand reputation.  

Pharma and biopharma manufacturers can engage with Mettler-Toledo experts on their virtual tour, taking the opportunity to discuss individual manufacturing issues and pain points, and the impact that product inspection can make in solving such issues. 

There are tours dedicated to pharmaceutical (solid) and biopharma (liquid) drug applications. Visitors will be guided through virtual factories, from preparation to packaging and can gain an overview of the wide variety of innovative solutions Mettler-Toledo provides across many production processes found within pharma/biopharma. In terms of Product Inspection technologies, customers will see solutions presented for physical contaminant detection (i.e. metal contaminants), fill level control, label and completeness checks, and serialisation and aggregation within these virtual environments. 

Miriam Krechlok, Pharma Marketing Expert, Mettler-Toledo Product Inspection said, “These personalised virtual tours are focused on presenting real-life product inspection solutions to real-life challenges that pharma and biopharma manufacturers face. Quality and safety standards don’t just protect the consumer – they serve to protect manufacturers too, and with these cutting-edge product inspection solutions, they can make sure they remain in full compliance with increasingly demanding legislation.”